A detailed history of Bridgeway Capital Management, LLC transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 312,700 shares of CHRS stock, worth $343,970. This represents 0.01% of its overall portfolio holdings.

Number of Shares
312,700
Previous 243,000 28.68%
Holding current value
$343,970
Previous $420,000 22.62%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.99 - $1.8 $69,003 - $125,460
69,700 Added 28.68%
312,700 $325,000
Q2 2024

Aug 14, 2024

BUY
$1.58 - $2.51 $383,940 - $609,930
243,000 New
243,000 $420,000

Others Institutions Holding CHRS

About Coherus BioSciences, Inc.


  • Ticker CHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,724,600
  • Market Cap $85.5M
  • Description
  • Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...
More about CHRS
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.